UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
UNH$407.46+0.6%Stored close · as of Nov 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Checking your notes…
| For the Years Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2023 | 2022 | 2021 |
| Operating activities | |||
| Net earnings | $23,144 | $20,639 | $17,732 |
| Noncash items: | |||
| Depreciation and amortization | 3,972 | 3,400 | 3,103 |
| Deferred income taxes | (245) | (673) | 130 |
| Share-based compensation | 1,059 | 925 | 800 |
| Other, net | (505) | (331) | (944) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (3,114) | (2,523) | (1,000) |
| Other assets | (2,444) | (1,374) | (1,031) |
| Medical costs payable | 3,482 | 4,053 | 2,701 |
| Accounts payable and other liabilities | 3,516 | 1,964 | 1,162 |
| Unearned revenues | 203 | 126 | (310) |
| Cash flows from operating activities | 29,068 | 26,206 | 22,343 |
| Investing activities | |||
| Purchases of investments | (18,314) | (18,825) | (17,139) |
| Sales of investments | 7,307 | 5,907 | 7,045 |
| Maturities of investments | 9,230 | 6,081 | 8,251 |
| Cash paid for acquisitions, net of cash assumed | (10,136) | (21,458) | (4,821) |
| Purchases of property, equipment and capitalized software | (3,386) | (2,802) | (2,454) |
| Cash received from dispositions | 685 | 3,414 | 15 |
| Other, net | (960) | (793) | (1,269) |
| Cash flows used for investing activities | (15,574) | (28,476) | (10,372) |
| Financing activities | |||
| Common share repurchases | (8,000) | (7,000) | (5,000) |
| Cash dividends paid | (6,761) | (5,991) | (5,280) |
| Proceeds from common stock issuances | 1,353 | 1,253 | 1,355 |
| Repayments of long-term debt | (2,125) | (3,015) | (3,150) |
| Proceeds from (repayments of) short-term borrowings, net | 11 | 732 | (1,302) |
| Proceeds from issuance of long-term debt | 6,394 | 14,819 | 6,933 |
| Customer funds administered | (521) | 5,548 | 622 |
| Purchases of redeemable noncontrolling interests | (730) | (176) | (1,338) |
| Other, net | (1,150) | (1,944) | (295) |
| Cash flows (used for) from financing activities | (11,529) | 4,226 | (7,455) |
| Effect of exchange rate changes on cash and cash equivalents | 97 | 34 | (62) |
| Increase in cash and cash equivalents | 2,062 | 1,990 | 4,454 |
| Cash and cash equivalents, beginning of period | 23,365 | 21,375 | 16,921 |
| Cash and cash equivalents, end of period | $25,427 | $23,365 | $21,375 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | $3,035 | $1,945 | $1,653 |
| Cash paid for income taxes | 6,078 | 5,222 | 3,966 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.